StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) stock

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3020% above fair value
$399.05−8.19 (-2.01%)

Close on Nov 20, 2026Market cap $138.33BP/E 48.3Yield –

Intuitive Surgical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Intuitive Surgical's free cash flow for the twelve months ending Sep 30, 2026 was $3.60B, up 58.4% year over year. For fiscal 2025 it was $2.49B, up 91.0% from the year before. Over ten years it grew 13.1% a year on average. The highest annual figure on record is $2.49B in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.49B+91.0%
FY2024Dec 31, 2024$1.30B+73.9%
FY2023Dec 31, 2023$749.60M-21.8%
FY2022Dec 31, 2022$958.40M-45.2%
FY2021Dec 31, 2021$1.75B+53.1%
FY2020Dec 31, 2020$1.14B-2.5%
FY2019Dec 31, 2019$1.17B+19.4%
FY2018Dec 31, 2018$982.20M+3.0%
FY2017Dec 31, 2017$953.20M-7.7%
FY2016Dec 31, 2016$1.03B+42.5%
FY2015Dec 31, 2015$725.20M+29.6%
FY2014Dec 31, 2014$559.50M-27.8%
FY2013Dec 31, 2013$775.40M+10.8%
FY2012Dec 31, 2012$700.00M+17.7%
FY2011Dec 31, 2011$594.70M+32.2%
FY2010Dec 31, 2010$449.80M+32.8%
FY2009Dec 31, 2009$338.80M+96.7%
FY2008Dec 31, 2008$172.20M-5.2%
FY2007Dec 31, 2007$181.68M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.11B+51.0%
Q2 FY2026Jun 30, 2026$948.40M+69.3%
Q1 FY2026Mar 31, 2026$808.60M+73.9%
Q4 FY2025Dec 31, 2025$730.00M+43.0%
Q3 FY2025Sep 30, 2025$735.60M+60.4%
Q2 FY2025Jun 30, 2025$560.10M+80.0%
Q1 FY2025Mar 31, 2025$465.00M+1878.7%
Q4 FY2024Dec 31, 2024$510.60M–
Q3 FY2024Sep 30, 2024$458.60M+57.0%
Q2 FY2024Jun 30, 2024$311.10M-36.2%
Q1 FY2024Mar 31, 2024$23.50M-86.7%
Q4 FY2023Dec 31, 2023-$207.20M-169.4%
Q3 FY2023Sep 30, 2023$292.10M+36.4%
Q2 FY2023Jun 30, 2023$487.40M+54.1%
Q1 FY2023Mar 31, 2023$177.30M+37.0%
Q4 FY2022Dec 31, 2022$298.70M-30.7%
Q3 FY2022Sep 30, 2022$214.10M-50.6%
Q2 FY2022Jun 30, 2022$316.20M-32.3%
Q1 FY2022Mar 31, 2022$129.40M-69.1%
Q4 FY2021Dec 31, 2021$430.80M-23.8%
Q3 FY2021Sep 30, 2021$433.10M+106.0%
Q2 FY2021Jun 30, 2021$467.00M+289.5%
Q1 FY2021Mar 31, 2021$419.00M+69.2%
Q4 FY2020Dec 31, 2020$565.60M+37.7%
Q3 FY2020Sep 30, 2020$210.20M-32.1%
Q2 FY2020Jun 30, 2020$119.90M-48.7%
Q1 FY2020Mar 31, 2020$247.60M+13.4%
Q4 FY2019Dec 31, 2019$410.70M+45.3%
Q3 FY2019Sep 30, 2019$309.60M+13.5%
Q2 FY2019Jun 30, 2019$233.90M+25.3%
Q1 FY2019Mar 31, 2019$218.40M-9.0%
Q4 FY2018Dec 31, 2018$282.60M-6.1%
Q3 FY2018Sep 30, 2018$272.80M-9.8%
Q2 FY2018Jun 30, 2018$186.70M+15.8%
Q1 FY2018Mar 31, 2018$240.10M+27.4%
Q4 FY2017Dec 31, 2017$301.00M-3.5%
Q3 FY2017Sep 30, 2017$302.50M–
Q2 FY2017Jun 30, 2017$161.20M–
Q1 FY2017Mar 31, 2017$188.50M–
Q4 FY2016Dec 31, 2016$311.90M–

More Intuitive Surgical figures

See a number that looks wrong?